Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with pain for ≥ 3 months following onset of a herpes zoster rash~Exclusion Criteria:~* Clinically significant intercurrent illness (e.g., endocrine, cardiac, hepatic, renal, neurologic, hematologic, skeletal) that the investigator determines could interfere with the efficacy or safety assessments.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- amitriptyline 4% ketamine 2% cream, placebo capsules (Type: ACTIVE_COMPARATOR): Np-1 cream and placebo gabapentin
- gabapentin capsules, placebo cream (Type: ACTIVE_COMPARATOR): gabapentin caps and placebo cream
- placebo cream and capsules (Type: PLACEBO_COMPARATOR): placebo cream and capsules

Based on this trial design, predict the completion outcome and termination type (if applicable).